pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 18·1 min read
save

Infant botulism cases linked to premium formulas raise safety concerns

Jun 18, 2026·read at STAT ↗RegulatoryNegative

Several infants fell ill with botulism after consuming infant formula from the premium brand ByHeart, and a second brand, Nara Organics, has also been implicated. Health officials say the outbreak highlights that higher-priced formulas are not automatically safer.

One child, now nearly two years old, survived thanks to the antitoxin BabyBIG administered when she was seven months old. Experts stress that the bacteria Clostridium botulinum can contaminate any product if manufacturing controls fail.

The incident is prompting food-safety regulators and consumer-advocacy groups to re-examine testing standards for infant nutrition products, and could lead to tighter oversight of formula production.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “New infant botulism outbreak puts fancy formulas under scrutiny”

read at STAT ↗
2,351 words · retrieved Jun 18
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

drugs
botulism immune globulin (human)2FENTANYL-37FENTANYL-75fentanylfentanyl CRfentanyl ER
topics
Recall3AdCom2GLP-1 receptorObesityPsychiatry & CNSVaccine

related stories

  • Sep 23The latest in the legal saga for youth gender-affirming care in the U.S.STAT
  • Jun 18Six of the biggest health news stories todaySTAT
  • Jun 18Super-potent synthetic opioids called nitazenes are spreading across the U.S.STAT
  • Sep 24One of the most contagious diseases on the planet is having its worst U.S. outbreak since 1991STAT
  • Sep 21President Trump’s newest vaccine ‘demands’ repeat old misinformationSTAT